CME Group (NASDAQ:CME) Announces Quarterly Earnings Results, Beats Estimates By $0.03 EPS

CME Group (NASDAQ:CME) posted its quarterly earnings results on Wednesday. The financial services provider reported $3.02 EPS for the quarter, topping analysts’ consensus estimates of $2.99 by $0.03, FiscalAI reports. The business had revenue of $1.74 billion during the quarter, compared to analysts’ expectations of $1.71 billion. CME Group had a net margin of 63.30% and a return on equity of 15.60%.

CME Group Stock Performance

Shares of CME stock opened at $295.31 on Wednesday. The firm has a market capitalization of $106.19 billion, a PE ratio of 25.05, a price-to-earnings-growth ratio of 3.79 and a beta of 0.24. The firm has a fifty day simple moving average of $275.44 and a two-hundred day simple moving average of $270.55. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group has a 12 month low of $218.31 and a 12 month high of $329.16.

CME Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, September 25th. Investors of record on Wednesday, September 9th were given a $1.30 dividend. The ex-dividend date of this dividend was Wednesday, September 9th. This represents a $5.20 annualized dividend and a yield of 1.8%. CME Group’s dividend payout ratio (DPR) is presently 44.11%.

Insiders Place Their Bets

In other CME Group news, Director Elizabeth Cook sold 500 shares of the company’s stock in a transaction on Monday, September 14th. The shares were sold at an average price of $280.11, for a total transaction of $140,055.00. Following the transaction, the director owned 17,916 shares in the company, valued at approximately $5,018,450.76. This represents a 2.72% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director William Shepard acquired 293 shares of the company’s stock in a transaction on Friday, September 25th. The stock was acquired at an average cost of $268.76 per share, for a total transaction of $78,746.68. Following the completion of the purchase, the director directly owned 263,289 shares of the company’s stock, valued at approximately $70,761,551.64. This represents a 0.11% increase in their position. The SEC filing for this purchase provides additional information. Corporate insiders own 0.30% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the stock. TD Cowen lifted their price target on shares of CME Group from $292.00 to $300.00 and gave the company a “buy” rating in a research note on Monday, October 5th. Deutsche Bank Aktiengesellschaft cut shares of CME Group from a “buy” rating to a “hold” rating and cut their price objective for the stock from $286.00 to $270.00 in a research report on Wednesday, August 19th. Morgan Stanley raised their target price on CME Group from $330.00 to $337.00 and gave the company an “overweight” rating in a research note on Friday, October 9th. UBS Group raised their target price on CME Group from $260.00 to $270.00 and gave the company a “neutral” rating in a research note on Monday, October 5th. Finally, Raymond James Financial reaffirmed an “outperform” rating and issued a $320.00 target price on shares of CME Group in a research report on Thursday, July 2nd. Nine analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $292.94.

CME Group News Summary

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Record revenue and earnings beat: Third-quarter revenue reached a record $1.74 billion, above the $1.71 billion consensus estimate, while adjusted EPS of $3.02 exceeded expectations of $2.99. Net income totaled $1.04 billion and operating income was $1.14 billion. CME Group Q3 earnings release
• Positive Sentiment: Trading volumes remained strong: Average daily volume rose to a third-quarter record of 29.4 million contracts, including 9 million contracts from outside the United States. Clearing and transaction-fee revenue reached $1.4 billion, supporting double-digit revenue and net-income growth. CME Q3 record revenue report
• Positive Sentiment: Market-data growth and capital returns: Market-data revenue increased 20% to a record $243 million. CME returned nearly $1 billion to shareholders through $465 million in dividends and $524 million in share repurchases, reinforcing its cash-generation profile.
• Positive Sentiment: Product expansion offers longer-term growth opportunities: CME is pursuing tungsten futures for the first half of 2027, pending regulatory approval, and has expanded its cryptocurrency derivatives offering with Bitcoin Cash and Uniswap futures. CME tungsten futures report
• Neutral Sentiment: Institutional positioning is mixed: JPMorgan and other investors added substantial CME shares, but several large firms, including T. Rowe Price, GQG Partners, FMR and Capital Research, reduced holdings.
• Negative Sentiment: Insider selling and regulatory uncertainty remain risks: Insiders made six sales versus three purchases over the past six months, including CEO Terrence Duffy’s sale of 50,000 shares. Separately, the CFTC is asking a court to dismiss CME’s lawsuit involving crypto perpetual futures, creating uncertainty around that initiative.

About CME Group

CME Group Inc operates global derivatives marketplaces that provide trading, clearing and settlement services for futures and options contracts. Its products cover major asset classes, including interest rates, equity indexes, foreign currencies, agricultural commodities, energy and metals. The company also provides market data, benchmark information and related services used by financial institutions, corporations, producers, investors and other market participants.

CME Group’s exchange portfolio includes CME, the Chicago Board of Trade, the New York Mercantile Exchange and COMEX.